×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

XOMA Corp. (XOMA) NASDAQ

$24.49 2.21 (9.92%)

Market Cap: $255.95M

As of 02/21/24 03:59 PM EST. Market closed.

(XOMA)

XOMA Corp. (XOMA)
NASDAQ

$24.49
2.21 (9.92%)

Market Cap: $255.95M

As of 02/21/24 03:59 PM EST. Market closed.

Add to Portfolio

xoma has an extensive portfolio of products, programs, and technologies that are the subject of licenses the company has in place with other biotech and pharmaceutical companies. many of these licenses are the result of the company's pioneering efforts in the discovery and development of antibody therapeutics. there are more than 20 such programs that are fully funded by partners and could ... read more

xoma has an extensive portfolio of products, programs, and technologies that are the subject of licenses the company has in place with other biotech and pharmaceutical companies. many of these licenses are the result of the company's pioneering efforts in the discovery and development of antibody therapeutics. there are more than 20 such programs that are fully funded by partners and could produce milestone payments and royalty payments in the future. in order to maximize its value in a licensing transaction, xoma continues to invest in x358, an allosteric monoclonal antibody that reduces insulin receptor activity, as the antibody could have a major impact on the treatment of hyperinsulinism. for more information, visit www.xoma.com. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$484,100
CEO Compensation (Total)
$1.32M
URL
Address
2910 7th St, California, Berkeley, 94710-2700.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
123
CEO Compensation (Base)
$484,100
CEO Compensation (Total)
$1.32M
Address
2910 7th St, California, Berkeley, 94710-2700.
PRICE CHART FOR XOMA CORP
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$22.95
Previous Close
$22.28
Days Range
$22.13 - $23.87
52 week range
$13.48 - $23.87
Volume
46,508
Avg. Volume (30 days)
20,775
Market Cap
$255.95M
Dividend Yield
-
P/E
(7.96)
Shares Outstanding
11,487,808
Open
$22.95
Previous Close
$22.28
Days Range
$22.13 - $23.87
52 week range
$13.48 - $23.87
Volume
46,508
Avg. Volume (30 days)
20,775
Market Cap
$255.95M
Dividend Yield
-
P/E
(7.96)
Shares Outstanding
11,487,808
FINANCIAL STATEMENTS FOR XOMA CORP
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR XOMA CORP
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Sitko BradleyChief Investment OfficerOct 03, 2023 Buy$13.892503,4735,600Oct 04, 2023, 04:30 PM
Sitko BradleyChief Investment OfficerOct 02, 2023 Buy$14.251,50021,3755,350Oct 04, 2023, 04:30 PM
Hughes OwenExec Chairman and Interim CEOOct 02, 2023 Buy$13.831,00013,8303,500Oct 04, 2023, 04:30 PM
Hughes OwenExec Chairman and Interim CEOSep 26, 2023 Buy$14.432,49936,0612,500Sep 27, 2023, 04:30 PM
Hughes OwenExec Chairman and Interim CEOSep 25, 2023 Buy$14.651151Sep 27, 2023, 04:30 PM
Sitko BradleyChief Investment OfficerMay 31, 2023 Buy$17.131,50025,7003,500Jun 02, 2023, 04:30 PM
Sitko BradleyChief Investment OfficerMay 23, 2023 Buy$19.0085016,1503,850May 25, 2023, 04:30 PM
Hughes OwenInterim CEOMay 23, 2023 Buy$23.4696822,706968May 25, 2023, 04:30 PM
Hughes OwenInterim CEOMay 24, 2023 Buy$23.791,03224,5512,000May 25, 2023, 04:30 PM
Sitko BradleyChief Investment OfficerMay 19, 2023 Buy$19.501,00019,5003,000May 22, 2023, 04:30 PM
Sitko BradleyChief Investment OfficerMay 16, 2023 Buy$23.2050011,6022,000May 17, 2023, 05:20 PM
Sitko BradleyChief Investment OfficerMay 15, 2023 Buy$23.401,50035,1001,500May 16, 2023, 04:13 PM
Sitko BradleyChief Investment OfficerMay 12, 2023 Buy$18.992,00037,9852,000May 16, 2023, 04:13 PM
BVF PARTNERS L P/ILDirectorJan 05, 2023 Buy$18.3919,000349,3191,788,168Jan 09, 2023, 05:44 PM
BVF PARTNERS L P/ILDirectorJan 06, 2023 Buy$21.983,24971,4191,789,844Jan 09, 2023, 05:44 PM
BVF PARTNERS L P/ILDirectorSep 27, 2022 Buy$16.891,68228,4091,784,838Sep 27, 2022, 07:22 PM
BVF PARTNERS L P/ILDirectorSep 26, 2022 Buy$16.836,360107,0501,783,834Sep 27, 2022, 07:22 PM
BVF PARTNERS L P/ILDirectorSep 23, 2022 Buy$16.5016,600273,8501,780,495Sep 27, 2022, 07:22 PM
BVF PARTNERS L P/ILDirectorSep 16, 2022 Buy$17.8924,293434,5361,773,780Sep 16, 2022, 06:30 PM
BVF PARTNERS L P/ILDirectorSep 15, 2022 Buy$17.965,575100,1381,576,913Sep 16, 2022, 06:30 PM
BVF PARTNERS L P/ILDirectorSep 14, 2022 Buy$17.2526,441456,0441,571,338Sep 16, 2022, 06:30 PM
BURNS THOMAS M.SVP, Finance & CFOJul 15, 2022 Option Exercise$4.032,0008,0608,555Jul 18, 2022, 04:30 PM
BURNS THOMAS M.SVP, Finance & CFOJul 15, 2022 Sale$31.662,00063,3216,555Jul 18, 2022, 04:30 PM
Neal James RCEOJul 15, 2022 Option Exercise$4.0325,000100,75036,822Jul 18, 2022, 04:30 PM
Neal James RCEOJul 15, 2022 Sale$29.8425,000746,10415,939Jul 18, 2022, 04:30 PM
Neal James RCEOMar 22, 2022 Option Exercise$4.032,3399,42614,161Mar 23, 2022, 06:52 PM
Neal James RCEOMar 21, 2022 Option Exercise$4.0350,000201,50061,822Mar 23, 2022, 06:52 PM
Neal James RCEOMar 23, 2022 Option Exercise$4.031,1114,47712,933Mar 23, 2022, 06:52 PM
Neal James RCEOMar 21, 2022 Sale$29.0050,0001,450,25011,822Mar 23, 2022, 06:52 PM
Neal James RCEOMar 23, 2022 Sale$30.021,11133,34811,822Mar 23, 2022, 06:52 PM
Neal James RCEOMar 22, 2022 Sale$30.022,33970,20911,822Mar 23, 2022, 06:52 PM
BURNS THOMAS M.SVP, Finance & CFOMar 22, 2022 Option Exercise$4.032,3399,4268,894Mar 23, 2022, 06:52 PM
BURNS THOMAS M.SVP, Finance & CFOMar 21, 2022 Option Exercise$4.0312,00048,36018,555Mar 23, 2022, 06:52 PM
BURNS THOMAS M.SVP, Finance & CFOMar 23, 2022 Option Exercise$4.031616496,716Mar 23, 2022, 06:52 PM
BURNS THOMAS M.SVP, Finance & CFOMar 21, 2022 Sale$29.0012,000348,0606,555Mar 23, 2022, 06:52 PM
BURNS THOMAS M.SVP, Finance & CFOMar 23, 2022 Sale$30.001614,8306,555Mar 23, 2022, 06:52 PM
BURNS THOMAS M.SVP, Finance & CFOMar 22, 2022 Sale$30.022,33970,2096,555Mar 23, 2022, 06:52 PM
Neal James RCEOApr 09, 2021 Option Exercise$25.008,000200,0008,000Apr 13, 2021, 04:30 PM
BURNS THOMAS M.SVP, Finance & CFOApr 09, 2021 Option Exercise$25.001,00025,0001,000Apr 13, 2021, 04:30 PM
VAN NESS W DENMANDirectorMar 15, 2021 Option Exercise$10.415,69959,33215,643Mar 16, 2021, 04:30 PM
Neal James RCEODec 15, 2020 Option Exercise$25.008,000200,0008,000Dec 17, 2020, 04:30 PM
Neal James RCEODec 15, 2020 Option Exercise$5.5026,000143,00046,849Dec 17, 2020, 04:30 PM
Neal James RCEODec 15, 2020 Sale$41.3526,0001,074,99826,555Dec 17, 2020, 04:30 PM
BURNS THOMAS M.SVP, Finance & CFODec 15, 2020 Option Exercise$25.002,00050,0002,000Dec 17, 2020, 04:30 PM
BURNS THOMAS M.SVP, Finance & CFODec 15, 2020 Option Exercise$4.0315,00060,45021,555Dec 17, 2020, 04:30 PM
BURNS THOMAS M.SVP, Finance & CFODec 15, 2020 Sale$41.4115,000621,08612,162Dec 17, 2020, 04:30 PM
Hernday NatashaDirectorDec 15, 2020 Option Exercise$25.004,000100,0004,000Dec 17, 2020, 04:30 PM
PERRY MATTHEW DDirectorDec 11, 2020 Buy$25.00200,0005,000,000200,000Dec 15, 2020, 07:12 PM
BVF PARTNERS L P/ILDirectorDec 11, 2020 Buy$25.00200,0005,000,000200,000Dec 15, 2020, 07:09 PM
Neal James RCEONov 23, 2020 Option Exercise$5.5013,12672,19333,975Nov 24, 2020, 04:30 PM
Neal James RCEONov 20, 2020 Option Exercise$5.506,87437,80727,723Nov 24, 2020, 04:30 PM
BURNS THOMAS M.SVP, Finance & CFONov 23, 2020 Option Exercise$4.035,12520,65411,680Nov 24, 2020, 04:30 PM
BURNS THOMAS M.SVP, Finance & CFONov 20, 2020 Option Exercise$4.036,87527,70613,430Nov 24, 2020, 04:30 PM
Neal James RCEONov 23, 2020 Sale$32.9613,126432,66220,849Nov 24, 2020, 04:30 PM
Neal James RCEONov 20, 2020 Sale$32.526,874223,52321,275Nov 24, 2020, 04:30 PM
BURNS THOMAS M.SVP, Finance & CFONov 23, 2020 Sale$32.935,125168,7526,555Nov 24, 2020, 04:30 PM
BURNS THOMAS M.SVP, Finance & CFONov 20, 2020 Sale$32.526,875223,5556,981Nov 24, 2020, 04:30 PM
Neal James RCEONov 05, 2020 Option Exercise$5.5010,00055,00030,849Nov 06, 2020, 05:20 PM
Neal James RCEONov 05, 2020 Sale$26.0210,000260,20521,576Nov 06, 2020, 05:20 PM
BURNS THOMAS M.SVP, Finance & CFONov 05, 2020 Option Exercise$4.038,00032,24014,555Nov 06, 2020, 05:20 PM
BURNS THOMAS M.SVP, Finance & CFONov 05, 2020 Sale$26.118,000208,9087,281Nov 06, 2020, 05:20 PM
BVF PARTNERS L P/ILDirectorSep 23, 2020 Buy$18.2017,089311,0162,040,124Sep 23, 2020, 07:26 PM
BVF PARTNERS L P/ILDirectorSep 22, 2020 Buy$18.4511,951220,4452,030,236Sep 23, 2020, 07:26 PM
BVF PARTNERS L P/ILDirectorSep 21, 2020 Buy$18.3922,328410,5022,023,276Sep 23, 2020, 07:26 PM
BVF PARTNERS L P/ILDirectorSep 04, 2020 Buy$18.777,737145,2282,011,017Sep 10, 2020, 08:10 AM
BVF PARTNERS L P/ILDirectorAug 31, 2020 Buy$18.4816,005295,7821,997,210Sep 01, 2020, 08:37 PM
BVF PARTNERS L P/ILDirectorAug 28, 2020 Buy$19.172,04439,1871,988,067Sep 01, 2020, 08:37 PM
BVF PARTNERS L P/ILDirectorSep 01, 2020 Buy$18.8717,572331,5152,007,110Sep 01, 2020, 08:37 PM
BVF PARTNERS L P/ILDirectorAug 25, 2020 Buy$19.755,687112,2901,986,945Aug 25, 2020, 08:10 PM
BVF PARTNERS L P/ILDirectorAug 24, 2020 Buy$19.3111,683225,5911,983,502Aug 25, 2020, 08:10 PM
BVF PARTNERS L P/ILDirectorAug 21, 2020 Buy$19.3210,805208,7701,976,998Aug 25, 2020, 08:10 PM
BVF PARTNERS L P/IL10% OwnerAug 18, 2020 Buy$19.2789517,2461,962,532Aug 20, 2020, 06:56 PM
BVF PARTNERS L P/IL10% OwnerAug 20, 2020 Buy$19.121,77233,8811,967,800Aug 20, 2020, 06:56 PM
BVF PARTNERS L P/IL10% OwnerAug 19, 2020 Buy$19.703,49668,8771,966,028Aug 20, 2020, 06:56 PM
BVF PARTNERS L P/IL10% OwnerAug 14, 2020 Buy$18.6921,922409,8101,961,637Aug 14, 2020, 06:38 PM
BVF PARTNERS L P/IL10% OwnerAug 13, 2020 Buy$17.801,05018,6931,939,715Aug 14, 2020, 06:38 PM
BVF PARTNERS L P/IL10% OwnerAug 12, 2020 Buy$17.344,05070,2331,938,665Aug 14, 2020, 06:38 PM
BVF PARTNERS L P/IL10% OwnerApr 15, 2020 Option Exercise$13.001,252,77216,286,0361,934,615Apr 17, 2020, 05:13 PM
BVF PARTNERS L P/IL10% OwnerMar 25, 2020 Buy$17.208,264142,1291,278,656Mar 27, 2020, 08:29 PM
Neal James RCEOMar 23, 2020 Buy$14.501,00014,50020,849Mar 24, 2020, 04:38 PM
Neal James RCEOMar 20, 2020 Buy$16.411,00016,41019,849Mar 23, 2020, 04:30 PM
BVF PARTNERS L P/IL10% OwnerMar 18, 2020 Buy$14.524,43964,4751,270,392Mar 20, 2020, 04:52 PM
BVF PARTNERS L P/IL10% OwnerMar 17, 2020 Buy$15.738,113127,6481,265,953Mar 17, 2020, 09:30 PM
BVF PARTNERS L P/IL10% OwnerMar 16, 2020 Buy$15.7310,164159,9161,257,840Mar 17, 2020, 09:30 PM
BVF PARTNERS L P/IL10% OwnerMar 13, 2020 Buy$18.34100,0001,834,0901,247,676Mar 17, 2020, 09:30 PM
Neal James RCEODec 23, 2019 Option Exercise$22.001,18025,96018,849Jan 16, 2020, 05:33 PM
BVF PARTNERS L P/IL10% OwnerDec 19, 2019 Buy$22.00373,1958,210,2901,147,676Dec 20, 2019, 07:18 PM
BVF PARTNERS L P/IL10% OwnerDec 18, 2019 Option Exercise$22.00472,26810,389,896940,442Dec 20, 2019, 07:18 PM
Neal James RCEONov 06, 2019 Option Exercise$5.504,34823,91422,017Nov 08, 2019, 04:30 PM
Neal James RCEONov 06, 2019 Sale$22.004,34895,65617,669Nov 08, 2019, 04:30 PM
Neal James RChief Executive OfficerSep 18, 2019 Option Exercise$5.503,83021,06521,499Sep 20, 2019, 07:40 PM
Neal James RChief Executive OfficerSep 20, 2019 Option Exercise$5.505,45229,98623,121Sep 20, 2019, 07:40 PM
Neal James RChief Executive OfficerSep 19, 2019 Option Exercise$5.506,37035,03524,039Sep 20, 2019, 07:40 PM
Neal James RChief Executive OfficerSep 20, 2019 Sale$20.235,452110,27117,669Sep 20, 2019, 07:40 PM
Neal James RChief Executive OfficerSep 19, 2019 Sale$21.126,370134,54420,311Sep 20, 2019, 07:40 PM
Neal James RChief Executive OfficerSep 18, 2019 Sale$21.963,83084,11317,669Sep 20, 2019, 07:40 PM
BURNS THOMAS M.Sr. VP, Finance and CFOSep 18, 2019 Option Exercise$4.033,82915,43110,384Sep 20, 2019, 07:39 PM
BURNS THOMAS M.Sr. VP, Finance and CFOSep 19, 2019 Option Exercise$4.034,17116,80910,726Sep 20, 2019, 07:39 PM
BURNS THOMAS M.Sr. VP, Finance and CFOSep 19, 2019 Sale$21.414,17189,2967,055Sep 20, 2019, 07:39 PM
BURNS THOMAS M.Sr. VP, Finance and CFOSep 18, 2019 Sale$21.963,82984,0916,555Sep 20, 2019, 07:39 PM
BVF PARTNERS L P/IL10% OwnerMay 14, 2019 Buy$14.7413,816203,664746,454May 14, 2019, 09:01 PM
BVF PARTNERS L P/IL10% OwnerMay 13, 2019 Buy$14.363,79754,526732,638May 14, 2019, 09:01 PM
BVF PARTNERS L P/IL10% OwnerMay 10, 2019 Buy$14.5710,300150,037728,841May 14, 2019, 09:01 PM
VAN NESS W DENMANDirectorMay 10, 2019 Sale$14.711301,9120May 14, 2019, 06:38 PM
Neal James RCEODec 20, 2018 Option Exercise$13.006788,81421,011Dec 21, 2018, 06:24 PM
VAN NESS W DENMANDirectorDec 20, 2018 Option Exercise$13.0080010,4009,944Dec 21, 2018, 06:22 PM
BVF PARTNERS L P/IL10% OwnerDec 17, 2018 Buy$14.1925,000354,792718,541Dec 19, 2018, 09:26 PM
BVF PARTNERS L P/IL10% OwnerDec 13, 2018 Buy$14.4124,253349,525693,541Dec 13, 2018, 06:54 PM
BVF PARTNERS L P/IL10% OwnerDec 12, 2018 Buy$14.752,81041,448669,288Dec 13, 2018, 06:54 PM
BVF PARTNERS L P/IL10% OwnerDec 11, 2018 Buy$14.509,400136,270666,478Dec 13, 2018, 06:54 PM
BVF PARTNERS L P/IL10% OwnerDec 06, 2018 Buy$14.8010,927161,698606,982Dec 10, 2018, 07:03 PM
BVF PARTNERS L P/IL10% OwnerDec 10, 2018 Buy$14.5418,081262,972657,078Dec 10, 2018, 07:03 PM
BVF PARTNERS L P/IL10% OwnerDec 07, 2018 Buy$14.7732,015472,778638,997Dec 10, 2018, 07:03 PM
BVF PARTNERS L P/IL10% OwnerDec 04, 2018 Buy$14.994,17162,515596,055Dec 04, 2018, 07:01 PM
BVF PARTNERS L P/IL10% OwnerDec 03, 2018 Buy$14.9080612,009591,884Dec 04, 2018, 07:01 PM
BVF PARTNERS L P/IL10% OwnerNov 30, 2018 Buy$14.854,82371,615591,078Dec 04, 2018, 07:01 PM
BVF PARTNERS L P/IL10% OwnerNov 27, 2018 Buy$15.2411,396173,680567,951Nov 29, 2018, 05:55 PM
BVF PARTNERS L P/IL10% OwnerNov 29, 2018 Buy$14.9310,016149,543586,255Nov 29, 2018, 05:55 PM
BVF PARTNERS L P/IL10% OwnerNov 28, 2018 Buy$15.118,288125,262576,239Nov 29, 2018, 05:55 PM
BVF PARTNERS L P/IL10% OwnerNov 21, 2018 Buy$15.0025,000374,892556,555Nov 21, 2018, 05:42 PM
BVF PARTNERS L P/IL10% OwnerNov 20, 2018 Buy$13.6837,482512,701531,555Nov 21, 2018, 05:42 PM
BVF PARTNERS L P/IL10% OwnerNov 19, 2018 Buy$13.939,771136,064494,073Nov 21, 2018, 05:42 PM
BVF PARTNERS L P/IL10% OwnerNov 16, 2018 Buy$13.8210,849149,986484,302Nov 19, 2018, 10:21 AM
BVF PARTNERS L P/IL10% OwnerNov 15, 2018 Buy$13.3121,141281,361473,453Nov 19, 2018, 10:21 AM
VAN NESS W DENMANDirectorNov 15, 2018 Option Exercise$6.857,69352,69914,672Nov 16, 2018, 04:31 PM
VAN NESS W DENMANDirectorNov 15, 2018 Sale$12.675,52870,0409,144Nov 16, 2018, 04:31 PM
Neal James RCEONov 13, 2018 Buy$13.264,00053,05620,333Nov 15, 2018, 04:09 PM
BURNS THOMAS M.SVP, Finance & CFOApr 27, 2018 Option Exercise$5.502,65514,6039,210Apr 27, 2018, 05:44 PM
BURNS THOMAS M.SVP, Finance & CFOApr 26, 2018 Option Exercise$5.508,34545,89814,900Apr 27, 2018, 05:44 PM
BURNS THOMAS M.SVP, Finance & CFOApr 27, 2018 Sale$24.772,65565,7576,555Apr 27, 2018, 05:44 PM
BURNS THOMAS M.SVP, Finance & CFOApr 26, 2018 Sale$24.698,345206,0506,555Apr 27, 2018, 05:44 PM
Neal James RCEOApr 27, 2018 Option Exercise$5.5015,65586,10331,988Apr 27, 2018, 05:44 PM
Neal James RCEOApr 26, 2018 Option Exercise$5.508,34545,89824,678Apr 27, 2018, 05:44 PM
Neal James RCEOApr 27, 2018 Sale$24.4215,655382,23616,333Apr 27, 2018, 05:44 PM
Neal James RCEOApr 26, 2018 Sale$24.698,345206,05016,333Apr 27, 2018, 05:44 PM
Neal James RCEONov 14, 2017 Option Exercise$4.038,58334,58924,916Nov 15, 2017, 08:03 PM
Neal James RCEONov 13, 2017 Option Exercise$4.0311,56846,61927,901Nov 15, 2017, 08:03 PM
Neal James RCEONov 15, 2017 Option Exercise$4.0326,145105,36442,478Nov 15, 2017, 08:03 PM
Neal James RCEONov 13, 2017 Sale$30.8311,568356,67416,817Nov 15, 2017, 08:03 PM
Neal James RCEONov 15, 2017 Sale$27.0326,145706,76618,533Nov 15, 2017, 08:03 PM
Neal James RCEONov 14, 2017 Sale$28.408,583243,74721,397Nov 15, 2017, 08:03 PM
BURNS THOMAS M.SVP, Finance & CFONov 14, 2017 Option Exercise$4.036,84727,59313,402Nov 15, 2017, 08:03 PM
BURNS THOMAS M.SVP, Finance & CFONov 13, 2017 Option Exercise$4.036,98328,14113,538Nov 15, 2017, 08:03 PM
BURNS THOMAS M.SVP, Finance & CFONov 15, 2017 Option Exercise$4.038,39233,82014,947Nov 15, 2017, 08:03 PM
BURNS THOMAS M.SVP, Finance & CFONov 14, 2017 Sale$28.346,847194,05310,585Nov 15, 2017, 08:03 PM
BURNS THOMAS M.SVP, Finance & CFONov 13, 2017 Sale$30.996,983216,4197,041Nov 15, 2017, 08:03 PM
BURNS THOMAS M.SVP, Finance & CFONov 15, 2017 Sale$27.058,392226,9786,755Nov 15, 2017, 08:03 PM
Varian JohnDirectorMay 16, 2017 Sale$6.2439,540246,9192,344May 18, 2017, 03:02 PM
Neal James RVP Business DevelopmentMar 21, 2017 Sale$5.405,10527,56915,366Mar 23, 2017, 10:45 AM
BURNS THOMAS M.VP, Finance & Chief FinancialMar 21, 2017 Sale$5.402,59814,0306,555Mar 23, 2017, 10:31 AM
Neal James RVP Business DevelopmentFeb 01, 2017 Sale$4.5219588120,566Feb 01, 2017, 04:47 PM
Neal James RVP Business DevelopmentJan 09, 2017 Sale$5.1512564420,666Jan 10, 2017, 12:21 PM
Varian JohnDirectorDec 21, 2016 Sale$5.7513,54977,90741,884Dec 23, 2016, 06:38 PM
SCANNON PATRICK J MD PHDExec. VP & CSODec 21, 2016 Sale$5.753,23018,5738,217Dec 23, 2016, 06:36 PM
Neal James RVP Business DevelopmentNov 01, 2016 Sale$5.2515078820,541Nov 03, 2016, 07:38 PM
Neal James RVP Business DevelopmentOct 07, 2016 Sale$0.452,5001,120413,839Oct 11, 2016, 05:26 PM
BURNS THOMAS M.VP, Finance & Chief FinancialMar 22, 2016 Sale$0.7819,24915,105183,071Mar 22, 2016, 09:05 PM
Neal James RVP Business DevelopmentMar 22, 2016 Sale$0.7819,81315,547411,339Mar 22, 2016, 09:03 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMar 22, 2016 Sale$0.7824,19418,985326,601Mar 22, 2016, 09:01 PM
SCANNON PATRICK J MD PHDExec. VP & CSOMar 22, 2016 Sale$0.7814,78511,602228,942Mar 22, 2016, 08:58 PM
Varian JohnCEOMar 22, 2016 Sale$0.7881,02263,5781,108,673Mar 22, 2016, 08:55 PM
SCANNON PATRICK J MD PHDExec. VP & CSOFeb 01, 2016 Sale$1.018,0008,08094,227Feb 03, 2016, 04:46 PM
SCANNON PATRICK J MD PHDExec. VP & CSODec 28, 2015 Sale$1.378,00010,937102,227Dec 30, 2015, 05:05 PM
SCANNON PATRICK J MD PHDExec. VP & CSONov 23, 2015 Sale$1.358,00010,800110,227Nov 25, 2015, 06:14 PM
SCANNON PATRICK J MD PHDExec. VP & CSOOct 26, 2015 Sale$1.048,0008,358118,227Oct 28, 2015, 05:44 PM
Varian JohnCEOAug 14, 2015 Option Exercise$0.8335,79929,838516,615Aug 18, 2015, 09:24 PM
SCANNON PATRICK J MD PHDExec. VP & CSOAug 14, 2015 Option Exercise$0.836,1575,132109,963Aug 18, 2015, 09:20 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOAug 14, 2015 Option Exercise$0.8310,8019,003138,292Aug 18, 2015, 08:24 PM
Neal James RVP Business DevelopmentAug 14, 2015 Option Exercise$0.839,0677,557175,402Aug 18, 2015, 07:49 PM
BAKER BROS. ADVISORS LPFormer 10% ownerJul 22, 2015 Sale$1.0911,000,00012,017,5003,153,539Jul 23, 2015, 05:35 PM
Varian JohnCEOJul 15, 2015 Option Exercise$1.2410,00012,400562,414Jul 17, 2015, 06:03 PM
Varian JohnCEOJul 15, 2015 Sale$4.4910,00044,869552,414Jul 17, 2015, 06:03 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJul 15, 2015 Option Exercise$3.045,00015,200127,345Jul 17, 2015, 06:02 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJul 15, 2015 Sale$4.605,00022,992122,345Jul 17, 2015, 06:02 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJul 10, 2015 Option Exercise$3.0429,00088,160151,345Jul 10, 2015, 06:57 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJul 09, 2015 Option Exercise$3.044,40013,376126,745Jul 10, 2015, 06:57 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJul 10, 2015 Sale$4.5529,000131,985122,345Jul 10, 2015, 06:57 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJul 09, 2015 Sale$4.554,40020,020122,345Jul 10, 2015, 06:57 PM
Varian JohnCEOJun 15, 2015 Option Exercise$1.2410,00012,400562,414Jun 17, 2015, 03:41 PM
Varian JohnCEOJun 15, 2015 Sale$3.6410,00036,362552,414Jun 17, 2015, 03:41 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMay 28, 2015 Sale$3.601,7886,437122,345Jun 01, 2015, 06:24 PM
Varian JohnCEOMay 15, 2015 Option Exercise$1.2410,00012,400562,414May 19, 2015, 06:08 PM
Varian JohnCEOMay 15, 2015 Sale$3.3410,00033,400552,414May 19, 2015, 06:08 PM
Varian JohnCEOApr 15, 2015 Option Exercise$1.2410,00012,400562,414Apr 15, 2015, 06:50 PM
Varian JohnCEOApr 15, 2015 Sale$3.8610,00038,606552,414Apr 15, 2015, 06:50 PM
KURLAND FREDCFO & VP FinanceApr 06, 2015 Option Exercise$3.6135,275127,25197,445Apr 07, 2015, 07:20 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMar 23, 2015 Sale$3.9432,742128,879119,467Mar 23, 2015, 06:35 PM
SCANNON PATRICK J MD PHDExec. VP & CSOMar 18, 2015 Option Exercise$4.018,66634,755121,353Mar 20, 2015, 07:30 PM
Klein ThomasChief Commercial OfficerMar 18, 2015 Option Exercise$4.0153,037212,705238,344Mar 20, 2015, 07:30 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMar 18, 2015 Option Exercise$4.0120,53582,356163,906Mar 20, 2015, 07:30 PM
Neal James RMar 18, 2015 Option Exercise$4.019,01936,171189,967Mar 20, 2015, 07:30 PM
KURLAND FREDCFO & VP FinanceMar 18, 2015 Option Exercise$4.019,16336,74875,156Mar 20, 2015, 07:30 PM
Varian JohnCEOMar 18, 2015 Option Exercise$4.0144,877179,979575,875Mar 20, 2015, 07:30 PM
Varian JohnCEOMar 16, 2015 Option Exercise$1.2410,00012,400570,384Mar 17, 2015, 06:52 PM
Varian JohnCEOMar 16, 2015 Sale$3.7210,00037,223560,384Mar 17, 2015, 06:52 PM
Varian JohnCEOFeb 17, 2015 Option Exercise$1.2410,00012,400377,184Feb 19, 2015, 06:09 PM
Varian JohnCEOFeb 17, 2015 Sale$3.5210,00035,192367,184Feb 19, 2015, 06:09 PM
SCANNON PATRICK J MD PHDExec. VP & CSOFeb 02, 2015 Sale$3.525,00017,62276,346Feb 03, 2015, 01:38 PM
Varian JohnCEOJan 15, 2015 Option Exercise$1.2410,00012,400377,184Jan 16, 2015, 05:22 PM
Varian JohnCEOJan 15, 2015 Sale$3.4610,00034,582367,184Jan 16, 2015, 05:22 PM
BAKER BROS. ADVISORS LPDirectorJan 06, 2015 Sale$3.861,000,0003,860,00012,589,950Jan 06, 2015, 08:31 PM
BAKER BROS. ADVISORS LPDirectorJan 05, 2015 Sale$3.811,003,3003,824,07813,449,938Jan 06, 2015, 08:31 PM
BAKER BROS. ADVISORS LPDirectorJan 02, 2015 Sale$3.55212,100753,74014,313,038Jan 06, 2015, 08:31 PM
SCANNON PATRICK J MD PHDExec. VP & CSOJan 02, 2015 Sale$3.555,00017,75681,346Jan 05, 2015, 05:32 PM
BAKER BROS. ADVISORS LPDirectorDec 26, 2014 Sale$3.71131,100486,46015,022,732Dec 30, 2014, 05:40 PM
BAKER BROS. ADVISORS LPDirectorDec 30, 2014 Sale$3.65391,9001,430,23914,495,492Dec 30, 2014, 05:40 PM
BAKER BROS. ADVISORS LPDirectorDec 29, 2014 Sale$3.68221,000812,44014,832,615Dec 30, 2014, 05:40 PM
BAKER BROS. ADVISORS LPDirectorDec 19, 2014 Sale$4.21752,9003,168,58015,135,587Dec 19, 2014, 05:13 PM
BAKER BROS. ADVISORS LPDirectorDec 18, 2014 Sale$4.29165,700710,68715,783,368Dec 19, 2014, 05:13 PM
BAKER BROS. ADVISORS LPDirectorDec 17, 2014 Sale$4.31686,5002,958,12915,925,911Dec 19, 2014, 05:13 PM
BAKER BROS. ADVISORS LPDirectorDec 12, 2014 Sale$4.71253,8001,196,41317,187,779Dec 16, 2014, 05:29 PM
BAKER BROS. ADVISORS LPDirectorDec 16, 2014 Sale$4.27319,2001,363,27116,516,549Dec 16, 2014, 05:29 PM
BAKER BROS. ADVISORS LPDirectorDec 15, 2014 Sale$4.45460,8002,050,65216,791,283Dec 16, 2014, 05:29 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMODec 15, 2014 Option Exercise$3.041,6004,86473,621Dec 16, 2014, 01:01 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMODec 15, 2014 Sale$4.631,6007,40172,021Dec 16, 2014, 01:01 PM
Varian JohnCEODec 15, 2014 Option Exercise$1.2410,00012,400377,184Dec 16, 2014, 01:01 PM
Varian JohnCEODec 15, 2014 Sale$4.4910,00044,929367,184Dec 16, 2014, 01:01 PM
BAKER BROS. ADVISORS LPDirectorDec 09, 2014 Sale$4.62392,3531,811,06217,406,162Dec 10, 2014, 05:50 PM
BAKER BROS. ADVISORS LPDirectorDec 03, 2014 Sale$4.84567,9182,748,83718,866,287Dec 04, 2014, 06:05 PM
BAKER BROS. ADVISORS LPDirectorDec 02, 2014 Sale$5.36500,0002,679,55019,353,087Dec 04, 2014, 06:05 PM
BAKER BROS. ADVISORS LPDirectorDec 04, 2014 Sale$4.551,304,2885,928,90217,743,703Dec 04, 2014, 06:05 PM
Neal James RVP Business DevelopmentNov 26, 2014 Sale$5.671,6789,514137,760Dec 01, 2014, 05:29 PM
SCANNON PATRICK J MD PHDExec. VP & CSODec 01, 2014 Sale$5.515,00027,56986,346Dec 01, 2014, 05:28 PM
Neal James RVP Business DevelopmentNov 24, 2014 Sale$5.031,0325,193139,438Nov 24, 2014, 06:25 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMONov 20, 2014 Option Exercise$3.045,00015,20077,021Nov 21, 2014, 02:46 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMONov 20, 2014 Sale$4.555,00022,75072,021Nov 21, 2014, 02:46 PM
KURLAND FREDCFO & VP FinanceNov 13, 2014 Sale$3.898,77334,14885,086Nov 17, 2014, 05:45 PM
SCANNON PATRICK J MD PHDExec. VP & CSONov 13, 2014 Sale$3.898,24532,09391,346Nov 17, 2014, 05:45 PM
Varian JohnCEONov 13, 2014 Sale$3.892,63010,237367,184Nov 17, 2014, 05:44 PM
Varian JohnCEONov 13, 2013 Sale$3.8956,214218,80792,525Nov 17, 2014, 05:44 PM
Neal James RVP Business DevelopmentNov 13, 2014 Sale$3.894,38717,076140,470Nov 17, 2014, 05:44 PM
SCANNON PATRICK J MD PHDExec. VP & CSONov 03, 2014 Sale$4.335,00021,66076,939Nov 03, 2014, 07:37 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOOct 28, 2014 Option Exercise$3.045,00015,20077,021Oct 29, 2014, 03:11 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOOct 28, 2014 Sale$4.575,00022,82972,021Oct 29, 2014, 03:11 PM
Varian JohnCEOOct 15, 2014 Option Exercise$1.2410,00012,400335,364Oct 15, 2014, 06:20 PM
Varian JohnCEOOct 15, 2014 Sale$3.8710,00038,690325,364Oct 15, 2014, 06:20 PM
SCANNON PATRICK J MD PHDExec. VP & CSOOct 01, 2014 Sale$4.095,00020,44781,939Oct 01, 2014, 06:15 PM
Varian JohnCEOSep 15, 2014 Option Exercise$1.2410,00012,400335,364Sep 16, 2014, 04:41 PM
Varian JohnCEOSep 15, 2014 Sale$4.5610,00045,577325,364Sep 16, 2014, 04:41 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOSep 15, 2014 Option Exercise$3.045,00015,20077,021Sep 16, 2014, 04:41 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOSep 15, 2014 Sale$4.595,00022,93872,021Sep 16, 2014, 04:41 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOSep 04, 2014 Option Exercise$3.0410,00030,40082,021Sep 08, 2014, 05:17 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOSep 04, 2014 Sale$4.5610,00045,64072,021Sep 08, 2014, 05:17 PM
SCANNON PATRICK J MD PHDExec. VP & CSOSep 02, 2014 Sale$4.315,00021,55386,939Sep 03, 2014, 02:42 PM
KURLAND FREDCFO & VP FinanceAug 15, 2014 Sale$4.3110,40144,78071,263Aug 19, 2014, 12:47 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOAug 18, 2014 Sale$4.3616,44971,75272,021Aug 19, 2014, 12:47 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOAug 15, 2014 Sale$4.3110,29944,34188,470Aug 19, 2014, 12:47 PM
Neal James RVP Business DevelopmentAug 15, 2014 Sale$4.616,58430,322144,857Aug 18, 2014, 06:21 PM
SCANNON PATRICK J MD PHDExec. VP & CSOAug 15, 2014 Sale$4.315,87125,27791,939Aug 18, 2014, 06:21 PM
Varian JohnCEOAug 15, 2014 Option Exercise$1.2410,00012,400335,364Aug 18, 2014, 06:21 PM
Varian JohnCEOAug 15, 2014 Sale$4.3064,823279,035325,364Aug 18, 2014, 06:21 PM
SCANNON PATRICK J MD PHDExec. VP & CSOAug 01, 2014 Sale$3.835,00019,16181,546Aug 04, 2014, 06:53 PM
Varian JohnCEOJul 15, 2014 Option Exercise$1.2410,00012,400295,613Jul 16, 2014, 05:18 PM
Varian JohnCEOJul 15, 2014 Sale$4.0310,00040,285285,613Jul 16, 2014, 05:18 PM
SCANNON PATRICK J MD PHDExec. VP & CSOJul 01, 2014 Sale$4.685,00023,41186,546Jul 02, 2014, 04:28 PM
Varian JohnCEOJun 16, 2014 Option Exercise$1.2410,00012,400295,613Jun 18, 2014, 05:14 PM
Varian JohnCEOJun 16, 2014 Sale$4.5410,00045,410285,613Jun 18, 2014, 05:14 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJun 16, 2014 Sale$4.5411,58052,59572,021Jun 18, 2014, 05:14 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMay 28, 2014 Sale$4.221,7857,53383,601May 29, 2014, 05:48 PM
Varian JohnCEOMay 15, 2014 Option Exercise$1.2410,00012,400295,613May 15, 2014, 05:49 PM
Varian JohnCEOMay 15, 2014 Sale$3.5510,00035,515285,613May 15, 2014, 05:49 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMay 13, 2014 Sale$3.8410,00038,40480,719May 15, 2014, 03:16 PM
Varian JohnCEOApr 15, 2014 Option Exercise$1.2410,00012,400295,613Apr 17, 2014, 04:28 PM
Varian JohnCEOApr 15, 2014 Sale$4.0610,00040,645285,613Apr 17, 2014, 04:28 PM
KURLAND FREDCFO & VP FinanceMar 18, 2014 Sale$6.325,91537,35962,600Mar 20, 2014, 03:39 PM
Varian JohnCEOMar 18, 2014 Sale$6.3221,329134,714285,613Mar 20, 2014, 03:39 PM
Neal James RVP Business DevelopmentMar 18, 2014 Sale$6.322,67116,870151,441Mar 20, 2014, 03:39 PM
Klein ThomasChief Commercial OfficerMar 18, 2014 Sale$6.3230,965195,57593,150Mar 20, 2014, 03:38 PM
SCANNON PATRICK J MD PHDExec. VP & CSOMar 18, 2014 Sale$6.323,41921,59491,546Mar 20, 2014, 03:38 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMar 18, 2014 Option Exercise$3.046,00018,24096,719Mar 20, 2014, 03:38 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMar 18, 2014 Sale$6.3117,649111,42390,719Mar 20, 2014, 03:38 PM
Varian JohnCEOMar 17, 2014 Option Exercise$1.2410,00012,400280,035Mar 18, 2014, 01:42 PM
Varian JohnCEOMar 17, 2014 Sale$6.0310,00060,292270,035Mar 18, 2014, 01:42 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOFeb 18, 2014 Option Exercise$3.046,00018,2409,228Feb 19, 2014, 04:36 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOFeb 18, 2014 Sale$7.556,00045,2723,228Feb 19, 2014, 04:36 PM
Varian JohnCEOFeb 18, 2014 Option Exercise$1.2410,00012,400158,739Feb 19, 2014, 04:36 PM
Varian JohnCEOFeb 18, 2014 Sale$7.5510,00075,478148,739Feb 19, 2014, 04:36 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJan 21, 2014 Option Exercise$3.045,69417,3108,922Jan 23, 2014, 05:25 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJan 21, 2014 Sale$8.276,00049,6083,228Jan 23, 2014, 05:25 PM
Varian JohnCEOJan 15, 2014 Option Exercise$1.2410,00012,400158,739Jan 17, 2014, 12:19 PM
Varian JohnCEOJan 15, 2014 Sale$8.2810,00082,791148,739Jan 17, 2014, 12:19 PM
SCANNON PATRICK J MD PHDExec. VP & CSOJan 09, 2014 Option Exercise$1.6920,00033,80062,017Jan 10, 2014, 03:00 PM
SCANNON PATRICK J MD PHDExec. VP & CSOJan 09, 2014 Sale$8.0020,000160,04242,017Jan 10, 2014, 03:00 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMODec 18, 2013 Option Exercise$3.046,00018,2409,534Dec 18, 2013, 06:54 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMODec 18, 2013 Sale$5.676,00033,9923,534Dec 18, 2013, 06:54 PM
Varian JohnCEODec 16, 2013 Option Exercise$1.2420,00024,800158,739Dec 18, 2013, 04:41 PM
Varian JohnCEODec 16, 2013 Sale$5.4420,000108,744148,739Dec 18, 2013, 04:41 PM
SCANNON PATRICK J MD PHDExec. VP & CSODec 02, 2013 Option Exercise$1.6920,00033,80058,682Dec 03, 2013, 04:22 PM
SCANNON PATRICK J MD PHDExec. VP & CSODec 02, 2013 Sale$6.0020,000120,00242,017Dec 03, 2013, 04:22 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMONov 27, 2013 Option Exercise$3.044,69614,2768,230Dec 02, 2013, 01:19 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMONov 27, 2013 Sale$4.544,69621,3203,534Dec 02, 2013, 01:19 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMONov 18, 2013 Option Exercise$2.361,3043,0774,838Nov 19, 2013, 03:20 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMONov 18, 2013 Sale$4.081,3045,3173,534Nov 19, 2013, 03:20 PM
Varian JohnCEONov 15, 2013 Option Exercise$1.2410,00012,400158,739Nov 15, 2013, 07:05 PM
Varian JohnCEONov 15, 2013 Sale$4.1310,00041,329148,739Nov 15, 2013, 07:05 PM
Varian JohnCEONov 13, 2013 Sale$3.9154,932214,938148,739Nov 15, 2013, 07:05 PM
SCANNON PATRICK J MD PHDExec. VP & CSONov 13, 2013 Sale$3.918,34632,66042,017Nov 15, 2013, 06:51 PM
KURLAND FREDCFO & VP FinanceNov 13, 2013 Sale$3.9112,33148,24422,085Nov 15, 2013, 06:48 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOOct 18, 2013 Sale$4.715,25424,7253,534Nov 01, 2013, 05:33 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOOct 18, 2013 Option Exercise$2.367461,7619,534Oct 21, 2013, 04:54 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOOct 18, 2013 Sale$4.717463,5118,788Oct 21, 2013, 04:54 PM
Varian JohnDirector and CEOOct 15, 2013 Option Exercise$1.2410,00012,400113,006Oct 16, 2013, 04:44 PM
Varian JohnDirector and CEOOct 15, 2013 Sale$4.5910,00045,950103,006Oct 16, 2013, 04:44 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOSep 30, 2013 Option Exercise$4.274591,9588,788Oct 02, 2013, 05:29 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOSep 18, 2013 Sale$4.536,00027,1878,329Sep 19, 2013, 05:50 PM
Varian JohnDirector and CEOSep 16, 2013 Option Exercise$1.2410,00012,400113,006Sep 17, 2013, 05:48 PM
Varian JohnDirector and CEOSep 16, 2013 Sale$4.5910,00045,862103,006Sep 17, 2013, 05:48 PM
BAKER BROS. ADVISORS LPDirectorAug 19, 2013 Buy$3.622,757,7919,983,20319,767,770Aug 21, 2013, 07:54 PM
BAKER BROS. ADVISORS LPDirectorAug 19, 2013 Option Exercise$3.622,757,7919,983,20319,767,770Aug 21, 2013, 05:07 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOAug 19, 2013 Sale$3.746,00022,41914,329Aug 19, 2013, 06:37 PM
Varian JohnDirector and CEOAug 15, 2013 Option Exercise$1.2410,00012,400113,006Aug 16, 2013, 07:57 PM
Varian JohnDirector and CEOAug 14, 2013 Sale$3.8651,647199,4198,432Aug 16, 2013, 07:57 PM
Varian JohnDirector and CEOAug 15, 2013 Sale$3.9210,00039,212103,006Aug 16, 2013, 07:57 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOAug 14, 2013 Sale$3.8610,52040,62120,329Aug 16, 2013, 07:49 PM
SCANNON PATRICK J MD PHDExec. VP & CSOAug 14, 2013 Sale$3.866,00223,17527,711Aug 16, 2013, 07:42 PM
KURLAND FREDCFO & VP FinanceAug 14, 2013 Sale$3.867,49828,95125,051Aug 16, 2013, 07:34 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJul 18, 2013 Option Exercise$2.736,00016,3717,353Jul 19, 2013, 02:59 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJul 18, 2013 Sale$4.716,00028,2334,101Jul 19, 2013, 02:59 PM
Varian JohnDirector and CEOJul 15, 2013 Option Exercise$1.2410,00012,40070,079Jul 17, 2013, 03:49 PM
Varian JohnDirector and CEOJul 15, 2013 Sale$4.8110,00048,06660,079Jul 17, 2013, 03:49 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJun 28, 2013 Option Exercise$3.455671,9554,101Jul 01, 2013, 04:24 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJun 18, 2013 Option Exercise$2.363,1307,3879,534Jun 18, 2013, 07:48 PM
Varian JohnDirector and CEOJun 17, 2013 Option Exercise$1.2410,00012,40070,079Jun 18, 2013, 07:33 PM
SCANNON PATRICK J MD PHDExec. VP & CSOJun 11, 2013 Option Exercise$1.6910,00016,90027,448Jun 12, 2013, 04:13 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMay 29, 2013 Sale$4.161,7977,4766,404May 29, 2013, 06:46 PM
WYSZOMIERSKI JACK LDirectorMay 28, 2013 Option Exercise$2.692,8007,5327,299May 29, 2013, 04:20 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMay 20, 2013 Option Exercise$2.367851,8539,534May 21, 2013, 07:24 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMay 20, 2013 Sale$4.167853,2668,749May 21, 2013, 07:24 PM
SCANNON PATRICK J MD PHDExec. VP & CSOMay 14, 2013 Option Exercise$1.6910,00016,90027,448May 15, 2013, 07:19 PM
Varian JohnDirector and CEOMay 15, 2013 Option Exercise$1.2410,00012,40070,079May 15, 2013, 07:15 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMar 28, 2013 Option Exercise$3.321,4984,96714,749Apr 01, 2013, 04:59 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOMar 19, 2013 Sale$3.296,99022,99713,251Mar 27, 2013, 05:31 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMODec 31, 2012 Option Exercise$2.288331,8992,036Jan 02, 2013, 04:57 PM
Varian JohnDirector and CEONov 14, 2012 Sale$2.5640,587103,80798,852Nov 15, 2012, 10:01 AM
SCANNON PATRICK J MD PHDExecutive Vice PresidentNov 14, 2012 Sale$2.568,77322,44517,448Nov 15, 2012, 10:01 AM
KURLAND FREDCFO & VP FinanceNov 14, 2012 Sale$2.569,11123,31013,485Nov 15, 2012, 10:01 AM
BAKER JULIANDirectorOct 29, 2012 Buy$3.004,722,66614,167,99817,888,512Oct 31, 2012, 05:02 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOSep 28, 2012 Option Exercise$3.515421,9001,203Oct 01, 2012, 06:02 PM
RUBIN PAUL DSr. VP Clinical Dev. & CMOJun 29, 2012 Option Exercise$2.836611,871661Jul 02, 2012, 05:52 PM
RUBIN PAUL DVP Clinical Dev. & CMOMar 30, 2012 Option Exercise$2.631,2293,2343,887Apr 02, 2012, 04:09 PM
VAN NESS W DENMANDirectorNov 11, 2011 Sale$1.606981,1172,600Nov 16, 2011, 02:56 PM
RUBIN PAUL DVP Clinical Dev. & CMOSep 30, 2011 Option Exercise$1.661,0221,6991,022Oct 03, 2011, 04:52 PM
KURLAND FREDCFO & VP FinanceMar 25, 2011 Buy$3.265,00016,3205,000Mar 28, 2011, 05:47 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Sitko BradleyChief Investment Officer10/03/20233,473
Sitko BradleyChief Investment Officer10/02/202321,375
Hughes OwenExec Chairman and Interim CEO10/02/202313,830
Hughes OwenExec Chairman and Interim CEO09/26/202336,061
Hughes OwenExec Chairman and Interim CEO09/25/202315
Sitko BradleyChief Investment Officer05/31/202325,700
Sitko BradleyChief Investment Officer05/23/202316,150
Hughes OwenInterim CEO05/23/202322,706
Hughes OwenInterim CEO05/24/202324,551
Sitko BradleyChief Investment Officer05/19/202319,500
Sitko BradleyChief Investment Officer05/16/202311,602
Sitko BradleyChief Investment Officer05/15/202335,100
Sitko BradleyChief Investment Officer05/12/202337,985
BVF PARTNERS L P/ILDirector01/05/2023349,319
BVF PARTNERS L P/ILDirector01/06/202371,419
BVF PARTNERS L P/ILDirector09/27/202228,409
BVF PARTNERS L P/ILDirector09/26/2022107,050
BVF PARTNERS L P/ILDirector09/23/2022273,850
BVF PARTNERS L P/ILDirector09/16/2022434,536
BVF PARTNERS L P/ILDirector09/15/2022100,138
BVF PARTNERS L P/ILDirector09/14/2022456,044
BURNS THOMAS M.SVP, Finance & CFO07/15/20228,060
BURNS THOMAS M.SVP, Finance & CFO07/15/202263,321
Neal James RCEO07/15/2022100,750
Neal James RCEO07/15/2022746,104
Neal James RCEO03/22/20229,426
Neal James RCEO03/21/2022201,500
Neal James RCEO03/23/20224,477
Neal James RCEO03/21/20221,450,250
Neal James RCEO03/23/202233,348
Neal James RCEO03/22/202270,209
BURNS THOMAS M.SVP, Finance & CFO03/22/20229,426
BURNS THOMAS M.SVP, Finance & CFO03/21/202248,360
BURNS THOMAS M.SVP, Finance & CFO03/23/2022649
BURNS THOMAS M.SVP, Finance & CFO03/21/2022348,060
BURNS THOMAS M.SVP, Finance & CFO03/23/20224,830
BURNS THOMAS M.SVP, Finance & CFO03/22/202270,209
Neal James RCEO04/09/2021200,000
BURNS THOMAS M.SVP, Finance & CFO04/09/202125,000
VAN NESS W DENMANDirector03/15/202159,332
Neal James RCEO12/15/2020200,000
Neal James RCEO12/15/2020143,000
Neal James RCEO12/15/20201,074,998
BURNS THOMAS M.SVP, Finance & CFO12/15/202050,000
BURNS THOMAS M.SVP, Finance & CFO12/15/202060,450
BURNS THOMAS M.SVP, Finance & CFO12/15/2020621,086
Hernday NatashaDirector12/15/2020100,000
PERRY MATTHEW DDirector12/11/20205,000,000
BVF PARTNERS L P/ILDirector12/11/20205,000,000
Neal James RCEO11/23/202072,193
Neal James RCEO11/20/202037,807
BURNS THOMAS M.SVP, Finance & CFO11/23/202020,654
BURNS THOMAS M.SVP, Finance & CFO11/20/202027,706
Neal James RCEO11/23/2020432,662
Neal James RCEO11/20/2020223,523
BURNS THOMAS M.SVP, Finance & CFO11/23/2020168,752
BURNS THOMAS M.SVP, Finance & CFO11/20/2020223,555
Neal James RCEO11/05/202055,000
Neal James RCEO11/05/2020260,205
BURNS THOMAS M.SVP, Finance & CFO11/05/202032,240
BURNS THOMAS M.SVP, Finance & CFO11/05/2020208,908
BVF PARTNERS L P/ILDirector09/23/2020311,016
BVF PARTNERS L P/ILDirector09/22/2020220,445
BVF PARTNERS L P/ILDirector09/21/2020410,502
BVF PARTNERS L P/ILDirector09/04/2020145,228
BVF PARTNERS L P/ILDirector08/31/2020295,782
BVF PARTNERS L P/ILDirector08/28/202039,187
BVF PARTNERS L P/ILDirector09/01/2020331,515
BVF PARTNERS L P/ILDirector08/25/2020112,290
BVF PARTNERS L P/ILDirector08/24/2020225,591
BVF PARTNERS L P/ILDirector08/21/2020208,770
BVF PARTNERS L P/IL10% Owner08/18/202017,246
BVF PARTNERS L P/IL10% Owner08/20/202033,881
BVF PARTNERS L P/IL10% Owner08/19/202068,877
BVF PARTNERS L P/IL10% Owner08/14/2020409,810
BVF PARTNERS L P/IL10% Owner08/13/202018,693
BVF PARTNERS L P/IL10% Owner08/12/202070,233
BVF PARTNERS L P/IL10% Owner04/15/202016,286,036
BVF PARTNERS L P/IL10% Owner03/25/2020142,129
Neal James RCEO03/23/202014,500
Neal James RCEO03/20/202016,410
BVF PARTNERS L P/IL10% Owner03/18/202064,475
BVF PARTNERS L P/IL10% Owner03/17/2020127,648
BVF PARTNERS L P/IL10% Owner03/16/2020159,916
BVF PARTNERS L P/IL10% Owner03/13/20201,834,090
Neal James RCEO12/23/201925,960
BVF PARTNERS L P/IL10% Owner12/19/20198,210,290
BVF PARTNERS L P/IL10% Owner12/18/201910,389,896
Neal James RCEO11/06/201923,914
Neal James RCEO11/06/201995,656
Neal James RChief Executive Officer09/18/201921,065
Neal James RChief Executive Officer09/20/201929,986
Neal James RChief Executive Officer09/19/201935,035
Neal James RChief Executive Officer09/20/2019110,271
Neal James RChief Executive Officer09/19/2019134,544
Neal James RChief Executive Officer09/18/201984,113
BURNS THOMAS M.Sr. VP, Finance and CFO09/18/201915,431
BURNS THOMAS M.Sr. VP, Finance and CFO09/19/201916,809
BURNS THOMAS M.Sr. VP, Finance and CFO09/19/201989,296
BURNS THOMAS M.Sr. VP, Finance and CFO09/18/201984,091
BVF PARTNERS L P/IL10% Owner05/14/2019203,664
BVF PARTNERS L P/IL10% Owner05/13/201954,526
BVF PARTNERS L P/IL10% Owner05/10/2019150,037
VAN NESS W DENMANDirector05/10/20191,912
Neal James RCEO12/20/20188,814
VAN NESS W DENMANDirector12/20/201810,400
BVF PARTNERS L P/IL10% Owner12/17/2018354,792
BVF PARTNERS L P/IL10% Owner12/13/2018349,525
BVF PARTNERS L P/IL10% Owner12/12/201841,448
BVF PARTNERS L P/IL10% Owner12/11/2018136,270
BVF PARTNERS L P/IL10% Owner12/06/2018161,698
BVF PARTNERS L P/IL10% Owner12/10/2018262,972
BVF PARTNERS L P/IL10% Owner12/07/2018472,778
BVF PARTNERS L P/IL10% Owner12/04/201862,515
BVF PARTNERS L P/IL10% Owner12/03/201812,009
BVF PARTNERS L P/IL10% Owner11/30/201871,615
BVF PARTNERS L P/IL10% Owner11/27/2018173,680
BVF PARTNERS L P/IL10% Owner11/29/2018149,543
BVF PARTNERS L P/IL10% Owner11/28/2018125,262
BVF PARTNERS L P/IL10% Owner11/21/2018374,892
BVF PARTNERS L P/IL10% Owner11/20/2018512,701
BVF PARTNERS L P/IL10% Owner11/19/2018136,064
BVF PARTNERS L P/IL10% Owner11/16/2018149,986
BVF PARTNERS L P/IL10% Owner11/15/2018281,361
VAN NESS W DENMANDirector11/15/201852,699
VAN NESS W DENMANDirector11/15/201870,040
Neal James RCEO11/13/201853,056
BURNS THOMAS M.SVP, Finance & CFO04/27/201814,603
BURNS THOMAS M.SVP, Finance & CFO04/26/201845,898
BURNS THOMAS M.SVP, Finance & CFO04/27/201865,757
BURNS THOMAS M.SVP, Finance & CFO04/26/2018206,050
Neal James RCEO04/27/201886,103
Neal James RCEO04/26/201845,898
Neal James RCEO04/27/2018382,236
Neal James RCEO04/26/2018206,050
Neal James RCEO11/14/201734,589
Neal James RCEO11/13/201746,619
Neal James RCEO11/15/2017105,364
Neal James RCEO11/13/2017356,674
Neal James RCEO11/15/2017706,766
Neal James RCEO11/14/2017243,747
BURNS THOMAS M.SVP, Finance & CFO11/14/201727,593
BURNS THOMAS M.SVP, Finance & CFO11/13/201728,141
BURNS THOMAS M.SVP, Finance & CFO11/15/201733,820
BURNS THOMAS M.SVP, Finance & CFO11/14/2017194,053
BURNS THOMAS M.SVP, Finance & CFO11/13/2017216,419
BURNS THOMAS M.SVP, Finance & CFO11/15/2017226,978
Varian JohnDirector05/16/2017246,919
Neal James RVP Business Development03/21/201727,569
BURNS THOMAS M.VP, Finance & Chief Financial03/21/201714,030
Neal James RVP Business Development02/01/2017881
Neal James RVP Business Development01/09/2017644
Varian JohnDirector12/21/201677,907
SCANNON PATRICK J MD PHDExec. VP & CSO12/21/201618,573
Neal James RVP Business Development11/01/2016788
Neal James RVP Business Development10/07/20161,120
BURNS THOMAS M.VP, Finance & Chief Financial03/22/201615,105
Neal James RVP Business Development03/22/201615,547
RUBIN PAUL DSr. VP Clinical Dev. & CMO03/22/201618,985
SCANNON PATRICK J MD PHDExec. VP & CSO03/22/201611,602
Varian JohnCEO03/22/201663,578
SCANNON PATRICK J MD PHDExec. VP & CSO02/01/20168,080
SCANNON PATRICK J MD PHDExec. VP & CSO12/28/201510,937
SCANNON PATRICK J MD PHDExec. VP & CSO11/23/201510,800
SCANNON PATRICK J MD PHDExec. VP & CSO10/26/20158,358
Varian JohnCEO08/14/201529,838
SCANNON PATRICK J MD PHDExec. VP & CSO08/14/20155,132
RUBIN PAUL DSr. VP Clinical Dev. & CMO08/14/20159,003
Neal James RVP Business Development08/14/20157,557
BAKER BROS. ADVISORS LPFormer 10% owner07/22/201512,017,500
Varian JohnCEO07/15/201512,400
Varian JohnCEO07/15/201544,869
RUBIN PAUL DSr. VP Clinical Dev. & CMO07/15/201515,200
RUBIN PAUL DSr. VP Clinical Dev. & CMO07/15/201522,992
RUBIN PAUL DSr. VP Clinical Dev. & CMO07/10/201588,160
RUBIN PAUL DSr. VP Clinical Dev. & CMO07/09/201513,376
RUBIN PAUL DSr. VP Clinical Dev. & CMO07/10/2015131,985
RUBIN PAUL DSr. VP Clinical Dev. & CMO07/09/201520,020
Varian JohnCEO06/15/201512,400
Varian JohnCEO06/15/201536,362
RUBIN PAUL DSr. VP Clinical Dev. & CMO05/28/20156,437
Varian JohnCEO05/15/201512,400
Varian JohnCEO05/15/201533,400
Varian JohnCEO04/15/201512,400
Varian JohnCEO04/15/201538,606
KURLAND FREDCFO & VP Finance04/06/2015127,251
RUBIN PAUL DSr. VP Clinical Dev. & CMO03/23/2015128,879
SCANNON PATRICK J MD PHDExec. VP & CSO03/18/201534,755
Klein ThomasChief Commercial Officer03/18/2015212,705
RUBIN PAUL DSr. VP Clinical Dev. & CMO03/18/201582,356
Neal James R03/18/201536,171
KURLAND FREDCFO & VP Finance03/18/201536,748
Varian JohnCEO03/18/2015179,979
Varian JohnCEO03/16/201512,400
Varian JohnCEO03/16/201537,223
Varian JohnCEO02/17/201512,400
Varian JohnCEO02/17/201535,192
SCANNON PATRICK J MD PHDExec. VP & CSO02/02/201517,622
Varian JohnCEO01/15/201512,400
Varian JohnCEO01/15/201534,582
BAKER BROS. ADVISORS LPDirector01/06/20153,860,000
BAKER BROS. ADVISORS LPDirector01/05/20153,824,078
BAKER BROS. ADVISORS LPDirector01/02/2015753,740
SCANNON PATRICK J MD PHDExec. VP & CSO01/02/201517,756
BAKER BROS. ADVISORS LPDirector12/26/2014486,460
BAKER BROS. ADVISORS LPDirector12/30/20141,430,239
BAKER BROS. ADVISORS LPDirector12/29/2014812,440
BAKER BROS. ADVISORS LPDirector12/19/20143,168,580
BAKER BROS. ADVISORS LPDirector12/18/2014710,687
BAKER BROS. ADVISORS LPDirector12/17/20142,958,129
BAKER BROS. ADVISORS LPDirector12/12/20141,196,413
BAKER BROS. ADVISORS LPDirector12/16/20141,363,271
BAKER BROS. ADVISORS LPDirector12/15/20142,050,652
RUBIN PAUL DSr. VP Clinical Dev. & CMO12/15/20144,864
RUBIN PAUL DSr. VP Clinical Dev. & CMO12/15/20147,401
Varian JohnCEO12/15/201412,400
Varian JohnCEO12/15/201444,929
BAKER BROS. ADVISORS LPDirector12/09/20141,811,062
BAKER BROS. ADVISORS LPDirector12/03/20142,748,837
BAKER BROS. ADVISORS LPDirector12/02/20142,679,550
BAKER BROS. ADVISORS LPDirector12/04/20145,928,902
Neal James RVP Business Development11/26/20149,514
SCANNON PATRICK J MD PHDExec. VP & CSO12/01/201427,569
Neal James RVP Business Development11/24/20145,193
RUBIN PAUL DSr. VP Clinical Dev. & CMO11/20/201415,200
RUBIN PAUL DSr. VP Clinical Dev. & CMO11/20/201422,750
KURLAND FREDCFO & VP Finance11/13/201434,148
SCANNON PATRICK J MD PHDExec. VP & CSO11/13/201432,093
Varian JohnCEO11/13/201410,237
Varian JohnCEO11/13/2013218,807
Neal James RVP Business Development11/13/201417,076
SCANNON PATRICK J MD PHDExec. VP & CSO11/03/201421,660
RUBIN PAUL DSr. VP Clinical Dev. & CMO10/28/201415,200
RUBIN PAUL DSr. VP Clinical Dev. & CMO10/28/201422,829
Varian JohnCEO10/15/201412,400
Varian JohnCEO10/15/201438,690
SCANNON PATRICK J MD PHDExec. VP & CSO10/01/201420,447
Varian JohnCEO09/15/201412,400
Varian JohnCEO09/15/201445,577
RUBIN PAUL DSr. VP Clinical Dev. & CMO09/15/201415,200
RUBIN PAUL DSr. VP Clinical Dev. & CMO09/15/201422,938
RUBIN PAUL DSr. VP Clinical Dev. & CMO09/04/201430,400
RUBIN PAUL DSr. VP Clinical Dev. & CMO09/04/201445,640
SCANNON PATRICK J MD PHDExec. VP & CSO09/02/201421,553
KURLAND FREDCFO & VP Finance08/15/201444,780
RUBIN PAUL DSr. VP Clinical Dev. & CMO08/18/201471,752
RUBIN PAUL DSr. VP Clinical Dev. & CMO08/15/201444,341
Neal James RVP Business Development08/15/201430,322
SCANNON PATRICK J MD PHDExec. VP & CSO08/15/201425,277
Varian JohnCEO08/15/201412,400
Varian JohnCEO08/15/2014279,035
SCANNON PATRICK J MD PHDExec. VP & CSO08/01/201419,161
Varian JohnCEO07/15/201412,400
Varian JohnCEO07/15/201440,285
SCANNON PATRICK J MD PHDExec. VP & CSO07/01/201423,411
Varian JohnCEO06/16/201412,400
Varian JohnCEO06/16/201445,410
RUBIN PAUL DSr. VP Clinical Dev. & CMO06/16/201452,595
RUBIN PAUL DSr. VP Clinical Dev. & CMO05/28/20147,533
Varian JohnCEO05/15/201412,400
Varian JohnCEO05/15/201435,515
RUBIN PAUL DSr. VP Clinical Dev. & CMO05/13/201438,404
Varian JohnCEO04/15/201412,400
Varian JohnCEO04/15/201440,645
KURLAND FREDCFO & VP Finance03/18/201437,359
Varian JohnCEO03/18/2014134,714
Neal James RVP Business Development03/18/201416,870
Klein ThomasChief Commercial Officer03/18/2014195,575
SCANNON PATRICK J MD PHDExec. VP & CSO03/18/201421,594
RUBIN PAUL DSr. VP Clinical Dev. & CMO03/18/201418,240
RUBIN PAUL DSr. VP Clinical Dev. & CMO03/18/2014111,423
Varian JohnCEO03/17/201412,400
Varian JohnCEO03/17/201460,292
RUBIN PAUL DSr. VP Clinical Dev. & CMO02/18/201418,240
RUBIN PAUL DSr. VP Clinical Dev. & CMO02/18/201445,272
Varian JohnCEO02/18/201412,400
Varian JohnCEO02/18/201475,478
RUBIN PAUL DSr. VP Clinical Dev. & CMO01/21/201417,310
RUBIN PAUL DSr. VP Clinical Dev. & CMO01/21/201449,608
Varian JohnCEO01/15/201412,400
Varian JohnCEO01/15/201482,791
SCANNON PATRICK J MD PHDExec. VP & CSO01/09/201433,800
SCANNON PATRICK J MD PHDExec. VP & CSO01/09/2014160,042
RUBIN PAUL DSr. VP Clinical Dev. & CMO12/18/201318,240
RUBIN PAUL DSr. VP Clinical Dev. & CMO12/18/201333,992
Varian JohnCEO12/16/201324,800
Varian JohnCEO12/16/2013108,744
SCANNON PATRICK J MD PHDExec. VP & CSO12/02/201333,800
SCANNON PATRICK J MD PHDExec. VP & CSO12/02/2013120,002
RUBIN PAUL DSr. VP Clinical Dev. & CMO11/27/201314,276
RUBIN PAUL DSr. VP Clinical Dev. & CMO11/27/201321,320
RUBIN PAUL DSr. VP Clinical Dev. & CMO11/18/20133,077
RUBIN PAUL DSr. VP Clinical Dev. & CMO11/18/20135,317
Varian JohnCEO11/15/201312,400
Varian JohnCEO11/15/201341,329
Varian JohnCEO11/13/2013214,938
SCANNON PATRICK J MD PHDExec. VP & CSO11/13/201332,660
KURLAND FREDCFO & VP Finance11/13/201348,244
RUBIN PAUL DSr. VP Clinical Dev. & CMO10/18/201324,725
RUBIN PAUL DSr. VP Clinical Dev. & CMO10/18/20131,761
RUBIN PAUL DSr. VP Clinical Dev. & CMO10/18/20133,511
Varian JohnDirector and CEO10/15/201312,400
Varian JohnDirector and CEO10/15/201345,950
RUBIN PAUL DSr. VP Clinical Dev. & CMO09/30/20131,958
RUBIN PAUL DSr. VP Clinical Dev. & CMO09/18/201327,187
Varian JohnDirector and CEO09/16/201312,400
Varian JohnDirector and CEO09/16/201345,862
BAKER BROS. ADVISORS LPDirector08/19/20139,983,203
BAKER BROS. ADVISORS LPDirector08/19/20139,983,203
RUBIN PAUL DSr. VP Clinical Dev. & CMO08/19/201322,419
Varian JohnDirector and CEO08/15/201312,400
Varian JohnDirector and CEO08/14/2013199,419
Varian JohnDirector and CEO08/15/201339,212
RUBIN PAUL DSr. VP Clinical Dev. & CMO08/14/201340,621
SCANNON PATRICK J MD PHDExec. VP & CSO08/14/201323,175
KURLAND FREDCFO & VP Finance08/14/201328,951
RUBIN PAUL DSr. VP Clinical Dev. & CMO07/18/201316,371
RUBIN PAUL DSr. VP Clinical Dev. & CMO07/18/201328,233
Varian JohnDirector and CEO07/15/201312,400
Varian JohnDirector and CEO07/15/201348,066
RUBIN PAUL DSr. VP Clinical Dev. & CMO06/28/20131,955
RUBIN PAUL DSr. VP Clinical Dev. & CMO06/18/20137,387
Varian JohnDirector and CEO06/17/201312,400
SCANNON PATRICK J MD PHDExec. VP & CSO06/11/201316,900
RUBIN PAUL DSr. VP Clinical Dev. & CMO05/29/20137,476
WYSZOMIERSKI JACK LDirector05/28/20137,532
RUBIN PAUL DSr. VP Clinical Dev. & CMO05/20/20131,853
RUBIN PAUL DSr. VP Clinical Dev. & CMO05/20/20133,266
SCANNON PATRICK J MD PHDExec. VP & CSO05/14/201316,900
Varian JohnDirector and CEO05/15/201312,400
RUBIN PAUL DSr. VP Clinical Dev. & CMO03/28/20134,967
RUBIN PAUL DSr. VP Clinical Dev. & CMO03/19/201322,997
RUBIN PAUL DSr. VP Clinical Dev. & CMO12/31/20121,899
Varian JohnDirector and CEO11/14/2012103,807
SCANNON PATRICK J MD PHDExecutive Vice President11/14/201222,445
KURLAND FREDCFO & VP Finance11/14/201223,310
BAKER JULIANDirector10/29/201214,167,998
RUBIN PAUL DSr. VP Clinical Dev. & CMO09/28/20121,900
RUBIN PAUL DSr. VP Clinical Dev. & CMO06/29/20121,871
RUBIN PAUL DVP Clinical Dev. & CMO03/30/20123,234
VAN NESS W DENMANDirector11/11/20111,117
RUBIN PAUL DVP Clinical Dev. & CMO09/30/20111,699
KURLAND FREDCFO & VP Finance03/25/201116,320
Load More Insider Transactions
FUNDS WITH A POSITION IN XOMA CORP
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.488,4850.00023%6.78%Other
GEODE CAPITAL MANAGEMENT, LLC160,9360.00031%2.68%Other
RENAISSANCE TECHNOLOGIES LLC12,2960.00035%-32.46%Other
CHANGE IN SHARES OUTSTANDING FOR XOMA CORP
STOCK BUYBACKS FOR XOMA CORP
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.06%
1Q
09/30/2023
03/31/2023
0.11%
2Q
09/30/2023
12/31/2022
0.18%
3Q
09/30/2023
09/30/2022
0.23%
4Q
09/30/2023
06/30/2022
0.46%
5Q
09/30/2023
03/31/2022
1.26%
6Q
09/30/2023
12/31/2021
-5.90%
7Q
09/30/2023
09/30/2021
1.43%
8Q
09/30/2023
06/30/2021
1.67%
9Q
09/30/2023
03/31/2021
2.07%
10Q
09/30/2023
12/31/2020
-0.26%
11Q
09/30/2023
09/30/2020
4.12%
12Q
09/30/2023
06/30/2020
6.00%
13Q
09/30/2023
03/31/2020
17.54%
14Q
09/30/2023
12/31/2019
30.93%
15Q
09/30/2023
09/30/2019
21.52%
16Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.06%
1Q
03/31/2023
0.11%
2Q
12/31/2022
0.18%
3Q
09/30/2022
0.23%
4Q
06/30/2022
0.46%
5Q
03/31/2022
1.26%
6Q
12/31/2021
-5.90%
7Q
09/30/2021
1.43%
8Q
06/30/2021
1.67%
9Q
03/31/2021
2.07%
10Q
12/31/2020
-0.26%
11Q
09/30/2020
4.12%
12Q
06/30/2020
6.00%
13Q
03/31/2020
17.54%
14Q
12/31/2019
30.93%
15Q
09/30/2019
21.52%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR XOMA CORP
LOADING...